Biopharmaceutical company licensing and developing drugs to treat fibrosis.
Sectors
Healthcare
Life Sciences
First Invested
2015
Early
Company Status
IPO/Acquired
NASDAQ: OKUR
Board Members
Website
Reneo PharmaceuticalsBiopharmaceutical company licensing and developing drugs to treat fibrosis.
